Stock Rating Downgrade
The Value Trend Rating for Bio-Rad Laboratories Inc (NYSE: BIO) fell significantly in the last week from A to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
Bio-Rad Laboratories Inc (NYSE: BIO) stock closed at $280.08 on 2/21/25 after a modest decline of -1.9%. Moreover, unusually high trading volume at 157% of normal accompanied the decline. The stock has declined -10.3% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Bio-Rad Laboratories has a current Value Trend Rating of C (Neutral). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Bio-Rad Laboratories has a neutral Appreciation Score of 45 and a slightly positive Power Rating of 68, resulting in the Neutral Value Trend Rating.
Be the first to comment